Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shujin Xiaotong capsule
- Development stage
- Preclinical
- Lead developer
- The Third Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Shujin Xiaotong capsule is a Traditional Chinese Medicine (TCM) preparation used for treating knee osteoarthritis, rheumatic bone pain, and related musculoskeletal conditions. The formulation is composed of six herbal ingredients: *Ligusticum wallichii* (Chuanxiong), *Angelica pubescens* (Duhuo), *Angelica sinensis* (Danggui), *Taxillus chinensis* (Sangjisheng), *Spatholobus suberectus* (Jixueteng), and *Dipsacus asper* (Xuduan). It functions by targeting inflammatory pathways, specifically inhibiting tumor necrosis factor-alpha (TNF-α) and the phosphorylation of nuclear factor kappa B (NF-κB). Research indicates that ligustrazine, a bioactive component from *Ligusticum wallichii*, plays a significant role in inhibiting chondrocyte apoptosis and reducing inflammatory markers, thereby facilitating articular cartilage repair and improving joint function.
- Brand names
- Shujin Xiaotong capsule
- Other names
- Shujin Xiaotong jiaonang
02
Targets
TNFA (Tumor necrosis factor alpha (soluble))NF-κB
Beyond the preview
Go deeper on Shujin Xiaotong capsule.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shujin Xiaotong capsule.